{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:20:52Z","timestamp":1759530052132},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1992,10,1]],"date-time":"1992-10-01T00:00:00Z","timestamp":717897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1992,10]]},"DOI":"10.1007\/bf02220613","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T08:16:06Z","timestamp":1128586566000},"page":"381-388","source":"Crossref","is-referenced-by-count":36,"title":["The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: Effect of dose, co-medication, and the presence of spina bifida"],"prefix":"10.1007","volume":"43","author":[{"given":"J. G. C.","family":"Omtzigt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Nau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J.","family":"Los","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Pijpers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lindhout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02220613_CR1","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","volume":"II","author":"E Robert","year":"1982","unstructured":"Robert E, Guibaud P (1982) Maternal valproic acid and congenital neural tube defects. Lancet II: 937","journal-title":"Lancet"},{"key":"BF02220613_CR2","first-page":"438","volume":"32","author":"Centers for Disease Control","year":"1983","unstructured":"Centers for Disease Control (1983) Valproate a new cause of birth defects \u2014 report from Italy and follow up from France. MMWR 32: 438\u2013439","journal-title":"MMWR"},{"key":"BF02220613_CR3","first-page":"768","volume":"219","author":"H Nau","year":"1981","unstructured":"Nau H, Rating D, Koch S, H\u00e4user I, Helge H (1981) Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother's milk and clinical status in neonates of epileptic mothers. J Pharmacol Exp Ther 219: 768\u2013777","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02220613_CR4","first-page":"131","volume-title":"Epilepsy, pregnancy and the child","author":"H Nau","year":"1982","unstructured":"Nau H, Wittfoht W, Rating D, Jakobs C, Sch\u00e4fer H, Helge H (1982) Pharmacokinetics of valproic acid and its metabolites in a pregnant patient: stable isotope methodology. In: Janz D, Bossi L, Dam M et al. (eds) Epilepsy, pregnancy and the child. Raven Press, New York, pp 131\u2013139"},{"key":"BF02220613_CR5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0022-3476(84)80567-3","volume":"104","author":"H Nau","year":"1984","unstructured":"Nau H, Helge H, Luck W (1984) Valproic acid in the perinatal period: decreased maternal serum protein binding results in fetal accumulation and neonatal displacement of the drug and some metabolites. J Pediatr 104: 627\u2013634","journal-title":"J Pediatr"},{"key":"BF02220613_CR6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/j.1552-4604.1986.tb02937.x","volume":"26","author":"H Nau","year":"1986","unstructured":"Nau H, Krauer B (1986) Serum protein binding of valproic acid in fetus-mother pairs throughout pregnancy: correlation with oxytocin administration and albumin and free fatty acid concentrations. J Clin Pharmacol 26: 215\u2013221","journal-title":"J Clin Pharmacol"},{"key":"BF02220613_CR7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2125.1987.tb03189.x","volume":"24","author":"T Kondo","year":"1987","unstructured":"Kondo T, Otani K, Hirano T, Kaneko S (1987) Placental transfer and neonatal elimination of mono-unsaturated metabolites of valproic acid. Br J Clin Pharmacol 24: 401\u2013402","journal-title":"Br J Clin Pharmacol"},{"key":"BF02220613_CR8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(84)90557-9","volume":"II","author":"D Lindhout","year":"1984","unstructured":"Lindhout D, Meinardi H (1984) Spina bifida and in-utero exposure to valproate. Lancet II: 396","journal-title":"Lancet"},{"issue":"Suppl 5","key":"BF02220613_CR9","first-page":"119","volume":"42","author":"JGC Omtzigt","year":"1992","unstructured":"Omtzigt JGC, Los FJ, Grobbee DE, Pijpers L, Jahoda MGJ, Brandenburg H, Stewart PA, Gaillard HLJ, Sachs ES, Wladimiroff JW, Lindhout D (1992) The risk of spina bifida aperta after first trimester valproate exposure in a prenatal cohort. Neurology 42 (Suppl 5): 119\u2013125","journal-title":"Neurology"},{"key":"BF02220613_CR10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/bmc.1130060108","volume":"6","author":"E Fisher","year":"1992","unstructured":"Fisher E, Wittfoht W, Nau H (1992) Quantitative determination of valproic acid and 14 metabolites in serum and urine by gas chromatography mass spectrometry. Biomed Chrom 6: 24\u201329","journal-title":"Biomed Chrom"},{"key":"BF02220613_CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/00498258409151426","volume":"14","author":"GR Granneman","year":"1984","unstructured":"Granneman GR, Wang SI, Machinist JM, Kesterson JW (1984) Aspects of the metabolism of valproic acid. Xenobiotica 14: 375\u2013387","journal-title":"Xenobiotica"},{"key":"BF02220613_CR12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003088-198815060-00002","volume":"15","author":"G Zaccara","year":"1988","unstructured":"Zaccara G, Messori A, Moroni F (1988) Clinical pharmacokinetics of valproic acid-1988. Clin Pharmacokin 15: 367\u2013389","journal-title":"Clin Pharmacokin"},{"key":"BF02220613_CR13","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/0006-291X(84)91214-2","volume":"122","author":"KS Pricket","year":"1984","unstructured":"Pricket KS, Baillie TA (1984) Metabolism of valproic acid by hepatic microsomal cytochrome p-450. Biochem Biophys Res Commun 122: 1166\u20131173","journal-title":"Biochem Biophys Res Commun"},{"key":"BF02220613_CR14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00007691-198903000-00002","volume":"11","author":"RG Dickinson","year":"1989","unstructured":"Dickinson RG, Hooper WD, Dunstan PR, Eadie MJ (1989) Urinary excretion of Valproate and some metabolites in chronically treated patients. Ther Drug Monit 11: 127\u2013133","journal-title":"Ther Drug Monit"},{"key":"BF02220613_CR15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/clpt.1986.144","volume":"40","author":"FS Abbott","year":"1986","unstructured":"Abbott FS, Kassam J, Orr JM, Farrell K (1986) The effect of aspirin on valproic acid metabolism. Clin Pharmacol Ther 40: 94\u2013100","journal-title":"Clin Pharmacol Ther"},{"key":"BF02220613_CR16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2125.1984.tb02414.x","volume":"17","author":"E Albani","year":"1984","unstructured":"Albani E, Riva R, Contin M, Baruzzi A, Altomare M, Merlini GP, Perucca E (1984) Differential transplacental binding of valproic acid: influence of free fatty acids. Br J Clin Pharmacol 17: 759\u2013762","journal-title":"Br J Clin Pharmacol"},{"key":"BF02220613_CR17","first-page":"1","volume-title":"Amniotic fluid: research and clinical application","author":"T McCarthy","year":"1978","unstructured":"McCarthy T, Saunders P (1978) The origin and circulation of the amniotic fluid. In: Fairweather DVI, Eskes TKAB (eds) Amniotic fluid: research and clinical application, 2nd rev. edn. Excerpta Medica, Amsterdam Oxford, pp 1\u201317","edition":"2nd rev. edn."},{"key":"BF02220613_CR18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/clpt.1986.160","volume":"40","author":"AE Rettie","year":"1986","unstructured":"Rettie AE, Rettenmeier AW, Beyer BK, Baillie TA, Juchau MR (1986) Valproate hydroxylation by human fetal tissues and embryotoxicity of metabolites. Clin Pharmacol Ther 40: 172\u2013177","journal-title":"Clin Pharmacol Ther"},{"key":"BF02220613_CR19","first-page":"71","volume":"1","author":"RG Dickinson","year":"1980","unstructured":"Dickinson RG, Lawyer CH, Kaufman SN, Lynn RK, Gerber N, Novy MJ, Cook MJ (1980) Materno-fetal pharmacokinetics and fetal distribution of valproic acid in a pregnant rhesus monkey. Pediatr Pharmacol 1: 71\u201383","journal-title":"Pediatr Pharmacol"},{"key":"BF02220613_CR20","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1111\/j.1528-1157.1984.tb05632.x","volume":"25","author":"H Nau","year":"1984","unstructured":"Nau H, Lascher W (1984) Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia 25 [Suppl] S14\u201322","journal-title":"Epilepsia"},{"key":"BF02220613_CR21","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0272-0590(86)90179-X","volume":"6","author":"H Nau","year":"1986","unstructured":"Nau H (1986) Valproic acid teratogenicity in mice after various administration and phenobarbital-pretreatment regimens: the parent drug and not one of the metabolites assayed is implicated as teratogen. Fund Appl Toxicol 6: 662\u2013668","journal-title":"Fund Appl Toxicol"},{"key":"BF02220613_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1042\/bst0130075","volume":"13","author":"NA Brown","year":"1985","unstructured":"Brown NA, Farmer PB, Coakley M (1985) Valproic acid teratogenicity: demonstration that the biochemical mechanism differs from that of Vaproate hepatotoxicity. Biochem Soc Trans 13: 75\u201377","journal-title":"Biochem Soc Trans"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02220613.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02220613\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02220613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T22:08:54Z","timestamp":1557871734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02220613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,10]]}},"alternative-id":["BF02220613"],"URL":"https:\/\/doi.org\/10.1007\/bf02220613","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,10]]}}}